iBio
IBIO
#10465
Rank
S$50.87 M
Marketcap
S$1.02
Share price
4.06%
Change (1 day)
-55.30%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2026 (TTM): S-$0.99

According to iBio's latest financial reports the company's current EPS (TTM) is S-$0.96. In 2025 the company made an earnings per share (EPS) of S-$2.24 an increase over its 2024 EPS that were of S-$8.32.

EPS history for iBio from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$0.99-55.69%
2025S-$2.24-73.08%
2024S-$8.32-93.88%
2023S-$135.95-8.14%
2022S-$148.0092.67%
2021S-$76.81-80.33%
2020S-$390.47-35.11%
2019S-$601.71-38.96%
2018S-$985.78-6.1%
2017S-$1,05036.67%
2016S-$768.1433.33%
2015S-$576.1150%
2014S-$384.07-53.85%
2013S-$832.16-7.14%
2012S-$896.17-64.1%
2011S-$2,49677.27%
2010S-$1,408144.44%
2009S-$576.1112.93%
2008S-$510.1612.2%
2007S-$454.68

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.18-1,264.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
S-$0.67-30.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
S-$8.58 793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S-$4.40 358.67%๐Ÿ‡บ๐Ÿ‡ธ USA